Events3rd International Electronic Conference on Medicinal Chemistry
Published
This submission belongs to the session D. Round Table on Parasitic Diseases of the event 3rd International Electronic Conference on Medicinal Chemistry
Published date
01 Nov, 2017
Citation
Pascal Marchand, Tien L. Huang, Annie Mayence, Nigel Yarlett, Identification of a Novel Potent and SelectiveAnti-Trichomonas vaginalis Agentamong Libraries of Bisbenzimidazoles, in Proceedings of 3rd International Electronic Conference on Medicinal Chemistry, 1 November–30 November 2017, MDPI: Basel, Switzerland, doi: 10.3390/ecmc-3-04685
Share
Email
Facebook
Twitter
LinkedIn

Identification of a Novel Potent and SelectiveAnti-Trichomonas vaginalis Agentamong Libraries of Bisbenzimidazoles

image
image
image
1. Université de Nantes, Cibles et médicaments des infections et du cancer, IICiMed, EA 1155, F-44000, Nantes, France
2. Division of Basic Pharmaceutical Sciences, College of Pharmacy, Xavier University of Louisiana, New Orleans, LA, USA
3. Haute Ecole Provinciale de Hainaut Condorcet, B-7330 Saint-Ghislain, Belgium
4. Department of Chemistry and Physical Sciences, Pace University, New York, NY, USA
5. Haskins Laboratories, Pace University, New York, NY, USA
Abstract

Small libraries of bisbenzimidazoles structurally related to pentamidine have been synthesized and evaluated against different species of parasites. 2,2’-[1,3-Propanediylbis(oxy-1,3-phenylene)]bis-1H-benzimidazole emerged as a potent and selective anti-Trichomonas vaginalis agent from in vitro and in vivo studies. In particular, in vitro under aerobic conditions the compound was more active than metronidazole against both metronidazole-susceptible (C1) and –refractory (085) isolates of Trichomonas vaginalis. In vivo, it cured a subcutaneous mouse model infection using both kinds of isolates.

Keywords
bisbenzimidazole
metronidazole
Trichomonas vaginalis
Manuscript
Poster
sciforum-014871ecmc-3(Tien).pdf
Synthesis of Novel N-{[4-(1,2,3-Triazol)pyridin-3-yl]sulfonyl}urea Derivatives With Potential Anticancer Activity
Procedures for the GMP-Compliant Production and Quality Control of [18F]PSMA-1007: A Next Generation Radiofluorinated Tracer for the Detection of Prostate Cancer